Overview
| Product name | Recombinant Human Insulin-like 3/INSL3 Protein |
|---|
| Catalog No. | RP00915 |
|---|
| Description | Recombinant Human Insulin-like 3/INSL3 Protein is produced by Human cells expression system. The target protein is expressed with sequence (Leu21-Tyr131) of human INSL3/Insulin-like 3 (Accession #P51460) fused with a 6×His tag at the C-terminus. |
|---|
| Purity | > 95% by SDS-PAGE. |
|---|
| Endotoxin | < 1 EU/μg of the protein by LAL method. |
|---|
| Formulation | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH7.4.Contact us for customized product form or formulation. |
|---|
| Species | Human |
|---|
| Calculated MW | 13.4 kDa |
|---|
Product information
| Synonym | INSL3; RLF; RLNL; ley-I-L |
|---|
| Expression Host | HEK293 cells |
|---|
| Tag | C-6×His |
|---|
| Swiss-Prot | |
|---|
| Gene ID | |
|---|
Usage guide
| Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt.
After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
|---|
| Reconstitution | Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
